login
login

Europe Daily Bulletin No. 13020

14 September 2022
Contents Publication in full By article 31 / 35
NEWS BRIEFS / Health
New Comirnaty vaccine for SARS-CoV-2 sub-variants adds to European vaccine portfolio

13/09/2022 (Agence Europe)The European Commission granted conditional marketing authorisation for a new adapted SARS-CoV-2 vaccine on Monday 12 September. This follows the recommendation published the same day by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) (see EUROPE B13019A12) in favour of authorising this vaccine. This bivalent messenger RNA vaccine developed by Pfizer-BioNTech targets the BA.4 and BA.5 sub-variants of concern of...

Contents

EUROPEAN PARLIAMENT PLENARY
SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
EXTERNAL ACTION
EU RESPONSE TO COVID-19
COURT OF JUSTICE OF THE EU
NEWS BRIEFS